Yuhan and Choongwe assessed as high growing potentiality.

Published: 2004-11-01 06:59:00

Updated: 2004-11-01 06:59:00

According to Hanyang security company's analysis Yuhan sales for the first 3 quarters grew up by 10.1% from the previous year term at 250,550 million won which reflected about 7,300 million won of loss accrued from the recall of Contact 600 and 3,978 million won of special losses. The operating i...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK